| For: | Rodriguez S, Dahlem MLF, Rossoni C, Marroni NP, Marroni CA, Fernandes SA. Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; 17(8): 108182 [PMID: 40901607 DOI: 10.4254/wjh.v17.i8.108182] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i8/108182.htm |
| Number | Citing Articles |
| 1 |
Curcumin as a multi-target therapeutic strategy in metabolic dysfunction-associated steatotic liver disease: integrating preclinical evidence with traditional chinese medicine perspectives. Pharmacological Research - Modern Chinese Medicine 2026; 20 doi: 10.1016/j.prmcm.2026.100850
|
| 2 |
Nuria Perez-Diaz-del-Campo, Miguel Lopez-Moreno, Begoña de Cuevillas, Diego Martinez-Urbistondo, J. Alfredo Martínez, Omar Ramos-Lopez. Nutriomic Technologies for Characterizing, Diagnosing, Clustering and Managing Chronic Liver Diseases: Precision Nutrition Implications. International Journal of Molecular Sciences 2026; 27(18) doi: 10.3390/ijms27188106
|
| 3 |
Li-Jie Zhao, Lu-Sheng Liao, Qin-Qin Long. Genetic Polymorphisms - From Mechanisms to Disease Implications and Therapeutic Perspectives [Working Title]. 2026; doi: 10.5772/intechopen.1017802
|
| 4 |
Barathan Muttiah, Gopinath Venkatraman, Puteri Shafinaz Abdul-Rahman. From metabolites to membrane vesicles: Unifying gut microbial signals in obesity, t2dm, and MASLD. World Journal of Microbiology and Biotechnology 2026; 42(9) doi: 10.1007/s11274-026-05249-6
|
| 5 |
Enrique Ángel-Gomis, Oriol Juanola, Esther Caparrós, Rubén Francés. Epigenetic reprogramming of hepatic antigen presenting cells in chronic liver disease. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1783588
|
| 6 |
Eslam Abady, Hazem AbuEl-Enien, Panos I. Tamvakologos, Karrar Naem Karam, Noor ul Ain Saleem, Abdul Haseeb Hasan, Staisy Mariyam Soju, Syeda Maham Guftar Shah, Maryam Nasir, Yahya Samadi, Zarqa Yasin. Ferroptosis may link gut microbiota dysbiosis to the progression of metabolic dysfunction associated steatotic liver disease. Discover Medicine 2026; 3(1) doi: 10.1007/s44337-026-00682-w
|
| 7 |
Donghyun Ko, Jordan Low, Peter Low, Damien Chua, Yock Young Dan, Vincent Chen, Jonathan A. Fallowfield, Timothy J. Kendall, Hirokazu Takahashi, Cheng Han Ng, Nicholas Syn, Mark Muthiah. Diversity in metabolic dysfunction-associated steatotic liver disease: a framework for precision medicine. npj Gut and Liver 2026; 3(1) doi: 10.1038/s44355-026-00061-3
|
| 8 |
Yan Li, Yuyuan Hu, Yuan He, Yuhang Yang, Dingwen Xue, Erkui Xue, Jinghan Jia, Wei Zhang, Jinxi Wang. Loss of immunometabolic adaptability in MASH: gut-derived signals drive macrophage reprogramming and fibrosis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1793092
|